The existence of a clear circadian rhythm in the local secretion of nasal IgA is a well-known phenomenon which is confirmed in the present research. Since the temporal pattern of secretory IgA (SIgA) strictly parallels the ACTH-cortisol cycle, a dependence was hypothesized in previous research, but the suppression of adrenal rhythm by means of massive doses of exogenous corticosteroids showed no influence on the SIgA cycle. In the present research a more sophisticated method of corticoid-incretion suppression was used; the single-dose suppression test with dexamethasone, which influences only the impulsive phase of the rhythm. In this case too, however, no influence was demonstrated on nasal SIgA secretion.
Get full access to this article
View all access options for this article.
References
1.
AlfordRHRossenRDButlerWDKasalJA. Neutralizing and hemagglutination inhibiting activity of nasal secretion following experimental human infection with A2 influenza virus. J Immunol1967; 98:724–31.
2.
AlfordRH. Antibody in nasal secretion after intramuscular injection of influenza virus vaccine in persons with chronic bronchopulmonary disease. J Immunol1969; 103:20–4.
3.
ArtensteinMSBellantiJABuescherEL. Identification of antiviral substances in nasal secretion. Proc Soc Exp Biol Med1964; 117:558–64.
4.
CouchRBDouglasRGJrRossenRKaselJA. Role of secretory antibody in influenza. In: DaytonDHSmallPAJrChanockRM, eds. The secretory immunologic system. Natl Inst Child Health and Human Development. Public Health Service, 1969: 93–112.
5.
de FazekasStGrothSDonnelleyM. Studies in experimental immunology of influenza; antibody response. Aust J Exp Biol Med Sci1950; 28:45–60.
6.
KaselJAHumeEDFulkRVTogoYHuberMHornickRB. Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine. J Immunol1969; 102:555–62.
7.
RossenRDButlerWTWaldmanRH. The proteins in nasal secretion: II. A longitudinal study of IgA and neutralizing antibody levels in nasal washings from men infected with influenza virus. JAMA1970; 211:1157–61.
8.
MannJJWaldmanRHTogoYHeinerGGDawkinsATKaselJA. Antibody response in respiratory secretions of volunteers given live and dead influenza virus. J Immunol1968; 100:726–35.
9.
WaldmanRHKaselJAFulkRV. Influenza antibody in human respiratory secretion after subcutaneous or respiratory immunization with inactivated virus. Nature1968; 218:594–6.
10.
WaldmanRHMannJJKaselJA. Influenza virus neutralizing antibody in human respiratory secretions. J Immunol1968; 100:80–5.
11.
SmithCBBellantiJAChanockR. Immunoglobulin in serum and nasal secretion following infections with type 1 parainfluenza virus and injection of inactivated vaccine. J Immunol1967; 99: 133–41.
12.
SmithCBPurcellRHBellantiJAChanockRM. The relative protective effect of antibody of parainfluenza type 1 virus in serum and nasal secretions. N Engl J Med1966; 275:1145–52.
13.
DouglasRGJrRossenRDButlerWTCouchRB. Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum. J Immunol1967; 99:297–303.
14.
RossenRDDouglasRGCateTRCouchRBButlerWT. The sedimentation behavior of rhinovirus neutralizing activity in nasal secretion and serum following the rhinovirus common cold. J Immunol1966; 97:532–8.
15.
PerkinsJCKnopfHLSKapikianAZChanockKM. The relative role of serum and nasal secretory neutralizing antibodies in protection against experimental rhinovirus illness. In: DaytonDHSmallPAJrChanockRM, eds. The secretory immunologic system.Natl Inst Child Health and Human Development, Public Health Service, 1969: 203–13.
16.
PerkinsJCTuckerDNKnopfHLS. Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route. Am J Epidemiol1969; 90:319–26.
17.
PerkinsJCTuckerDNKnopfHLSWenzelRPKapikianAZChanockRM. Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness. Am J Epidemiol1969; 90:519–26.
18.
KnopfHLSPerkinsJCBertranDMKapikianAZChanockRM. Analysis of the neutralizing activity in nasal wash and serum following intranasal vaccination with inactivated type 13 rhinovirus. J Immunol1970; 104:566–73.
19.
BellantiJASangaRLKlutinisBBrandtBArtensteinMS. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. N Engl J Med1969; 280:628–33.
20.
OgraPLKarzonDTRighthandFMacgillivryM. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med1968; 279:893–900.
21.
OgraPLKarzonDT. Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine. J Immunol1969; 102:15–23.
22.
OgraPLKarzonDT. Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol1969; 102:1423–30.
23.
BellantiJASmithGBKimWH. Serum and local respiratory antibody responses following infection with mycoplasma pneumoniae or RSV. In: DaytonDHSmallPAJrChanockRM, eds. The secretory immunologic system.Natl Inst Child Health and Human Development, Public Health Service, 1969: 183–93.
24.
FernaldGW. Local immune mechanisms in respiratory infection due to mycoplasma pneumoniae. In: DaytonDHSmallPAJrChanockRM, eds. The secretory immunologic system.Natl Inst Child Health and Human Development, Public Health Service, 1969: 215–27.
25.
BellantiJA. Studies of local and serum antibody responses to infection with francisella tularensis and adenovirus. In: DaytonDHSmallPAJrChanockRM, eds. The secretory immunologic system. Natl Inst Child Health and Human Development, Public Health Service, 1969: 237–44.
26.
KimHWBellantiJAArrobioJA. Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection. Proc Soc Exp Biol Med1969; 131:658–61.
27.
MillsJMKnopfHLSVankirkJChanockRM. Significance of local respiratory tract antibody to respiratory syncytial virus. In: DaytonDHSmallPAJrChanockRM, eds. The secretory immunologic system. Natl Inst Child Health and Human Development, Public Health Service, 1969:149–65.
28.
ParrottRHKimHWBellantiJA. Development of nasal secretion neutralizing activity in infants and children following natural RSV infection or administration of cold-adapted RS A2 virus. In: DaytonDHSmallPAJrChanockRM, eds. The secretory immunologic system. Natl Inst Child Health and Human Development, Public Health Service, 1969: 167–82.
29.
TomasiTBTanEMSolomonAPrendergastRA. Characteristics of immune system common to certain external secretions. J Exp Med1965; 121:101–24.
30.
TomasiTB. Human Immunoglobulin A. N Engl J Med1968; 279:1327–30.
31.
TomasiTBGreyHM. Structure and function of immunoglobulin A. Prog Allergy1972; 16:81–213.
HeremansJF. Immunoglobulin formation and function in different tissues. Curr Top Microbiol Immunol1968; 45:131–203.
34.
Fazekas de St GrothSDonnellyM. Studies in experimental immunology of influenza: Pathotropic adjuvants. Aust J Exp Biol Med Sci1951; 29:323–35.
35.
Fazekas de St GrothS. Influenza: A study in mice. Lancet1950: 1:1101–5.
36.
RossenRDSchadeALButlerWTKaselJA. The proteins in nasal secretions: A longitudinal study of the IgA, IgG, albumin, siderophilin and total protein concentrations in nasal washings from adult male volunteers. J Clin Invest1966; 45:768–75.
37.
HughesECJohnsonRL. Circadian and interpersonal variability of IgA in nasal secretions. Ann Otol Rhinol Laryngol1973; 82:216–22.
38.
HughesECJohnsonRLWhitakerCW. Circadian rhythmic aspects of secretory immunoglobulin A. In: McGovernJPSmolenskyMHReinbergA, eds. Chronobiology in allergy and immunology. Springfield: Charles C. Thomas, 1977: 216–32.
